Hepatotoxicity of stanozolol in cats

Journal of the American Veterinary Medical Association

Volumn 217, Issue 5, 2000, Pages 681-684

  Harkin, Kenneth R ^a   Cowan, Laine A ^a,b   Andrews, Gordon A ^a   Basaraba, Randall J ^a,c   Fischer, Julie R ^a   DeBowes, Linda J ^a   Roush, James K ^a   Guglielmino, Maria L ^a   Kirk, Claudia A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b Phoenix Central Laboratory   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; STANOZOLOL; UREA; VITAMIN K GROUP;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CAT; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME ACTIVITY; GINGIVITIS; HISTOPATHOLOGY; LIVER BIOPSY; LIVER TOXICITY; NONHUMAN; STOMATITIS;

EID: 0034284082     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2000.217.681     Document Type: Article

References (10)

1. Dennis JS. Anabolic steroids: their potential in small animals. Compend Contin Educ Pract Vet 1990;12:1403-1410.
2. Abbate S. Anabolic therapy Winstrol-V product information release. Kalamazoo, Mich: Pharmacia and Upjohn, 1995.
3. Cowan LA, McLaughlin R, Toll PW, et al. Effect of stanozolol on body composition, nitrogen balance, and food consumption in castrated dogs with chronic renal failure. J Am Vet Med Assoc 1997;211:719-722.
4. Strauss RH. Anabolic steroids in the athlete. Annu Rev Med 1991;42:449-457.
5. Yoshida EM, Karim MA, Shaikh JF, et al. At what price glory? Severe cholestasis and acute renal failure in an athlete abusing stanuzolol. Can Med Assoc 1994;151:791-793.
6. Welder AA, Robertson JW, Melchert RB. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. J Pharmacol Toxicol Methods 1995;33:187-195.
7. Gurakar A, Caraceni P, Fagiuoli S, et al. Androgenic/anabolic steroid-induced intrahepatic cholestasis: a review with four additional case reports. J Okla State Med Assoc 1994;87:399-404.
8. Fernandez L, Chirino R, Boada LD, et al. Stanozolol and danazol, unlike natural androgens, interact with the low affinity glucocorticoid-binding sites from male rat liver microsomes. Endocrinology 1994;134:1401-1408.
9. King PD, Blitzer BL Drug-induced cholestasis: pathogenesis and clinical features. Semin Liver Dis 1990;10:316-321.
10. Biourge VC, Groff JM, Munn RJ, et al. Experimental induction of hepatic lipidosis in cats. Am J Vet Res 1994;55:1291-1302.